Tokyo, July 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062134) titled 'Effect of 4-week glucosamine supplementation on urinary cartilage degradation markers in street dancers (a double-blind, randomized, parallel-group comparative study)' on July 6.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Gunma University

Condition: Condition - knee pain Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Verification of whether glucosamine reduces urinary markers of cartilage degradation. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Taking glucosamine supplements Interventions/Control_2 - Taking tablets containing neither glucosamine nor mucopolysaccharides.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1) Individuals aged 18 years or older at the time of obtaining consent 2) Individuals who practice street dance on a regular basis (3 days or more per week) 3) Individuals with no abnormalities or discomfort in their joints 4) Individuals not currently undergoing treatment for internal medical conditions or orthopedic disorders (at the start of the study) 5) Individuals who have received an explanation of the study details, have fully understood them, and have provided written consent to participate Key exclusion criteria - Patients meeting any of the following criteria will be excluded from the study: 1) Individuals with food allergies to crustaceans (shrimp or crab), pork, chicken, soybeans, or gelatin. 2) Individuals determined to require further medical evaluation by the participating physician (orthopedic surgeon) based on the questionnaire, JKOM, and JLEQ. 3) Individuals testing positive (1+ or higher on a test strip) for urinary glucose, protein, or occult blood in a urinalysis. 4) Women who are pregnant, breastfeeding, or potentially pregnant. 5) Individuals otherwise deemed unsuitable by the principal investigator or participating physician. Target Size - 72

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 07 Month 01 Day Date of IRB - 2026 Year 07 Month 02 Day Anticipated trial start date - 2026 Year 07 Month 08 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071091

Disclaimer: Curated by HT Syndication.